Showing results (261-270 of 1,014) with videos related to
Sort By:
Pageof 102
Neurology|June 1, 1977
Interaction between bromocriptine and levodopa. Biochemical basis for an improved treatment for parkinsonismC S Hutt, S R Snider, S FahnBrain Research|July 26, 1988
The iminodipropionitrile (IDPN) model of persistent spasmodic dyskinesias: regional serotonin metabolism in rat brainJ L Cadet, V Jackson-Lewis, S FahnMovement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986
Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four-year periodN Quinn, D Parkes, I Janota, et al.Neurologia (Barcelona, Spain)|July 1, 1989
[Pharmacologic, surgical and infiltration of botulin toxin treatment in blepharospasm]F Grandas, J Elston, N Quinn, et al.Neuroscience|November 1, 1983
Alterations in cerebral dopamine function caused by administration of cis- or trans-flupenthixol for up to 18 monthsK Murugaiah, A Theodorou, P Jenner, et al.European Journal of Pharmacology|October 6, 1987
Pilocarpine-induced purposeless chewing behaviour in rats is dependent on intact central stores of 5-HTB Stewart, S Rose, P Jenner, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1991
Paroxysmal dystonic head tremorA J Hughes, A J Lees, C D MarsdenMovement Disorders : Official Journal of the Movement Disorder Society|March 26, 1999
The vulnerability of nigral neurons to Parkinson's disease is unrelated to their intrinsic capacity for dopamine synthesis: an in situ hybridization studyA E Kingsbury, C D Marsden, O J FosterYonsei Medical Journal|May 19, 2000
The pedunculopontine nucleus: its role in the genesis of movement disordersM S Lee, J O Rinne, C D MarsdenPageof 102